Monocrotaline-Induced Pulmonary Hypertension Involves Downregulation of Antiaging Protein Klotho and eNOS Activity.
The objective of this study is to investigate whether stem cell delivery of secreted Klotho (SKL), an aging-suppressor protein, attenuates monocrotaline-induced pulmonary vascular dysfunction and remodeling. Overexpression of SKL in mesenchymal stem cells (MSCs) was achieved by transfecting MSCs with lentiviral vectors expressing SKL-green fluorescent protein (GFP). Four groups of rats were treated with monocrotaline, whereas an additional group was given saline (control). Three days later, 4 monocrotaline-treated groups received intravenous delivery of nontransfected MSCs, MSC-GFP, MSC-SKL-GFP, and PBS, respectively. Ex vivo vascular relaxing responses to acetylcholine were diminished in small pulmonary arteries (PAs) in monocrotaline-treated rats, indicating pulmonary vascular endothelial dysfunction. Interestingly, delivery of MSCs overexpressing SKL (MSC-SKL-GFP) abolished monocrotaline-induced pulmonary vascular endothelial dysfunction and PA remodeling. Monocrotaline significantly increased right ventricular systolic blood pressure, which was attenuated significantly by MSC-SKL-GFP, indicating improved PA hypertension. MSC-SKL-GFP also attenuated right ventricular hypertrophy. Nontransfected MSCs slightly, but not significantly, improved PA hypertension and pulmonary vascular endothelial dysfunction. MSC-SKL-GFP attenuated monocrotaline-induced inflammation, as evidenced by decreased macrophage infiltration around PAs. MSC-SKL-GFP increased SKL levels, which rescued the downregulation of SIRT1 (Sirtuin 1) expression and endothelial NO synthase (eNOS) phosphorylation in the lungs of monocrotaline-treated rats. In cultured endothelial cells, SKL abolished monocrotaline-induced downregulation of eNOS activity and NO levels and enhanced cell viability. Therefore, stem cell delivery of SKL is an effective therapeutic strategy for pulmonary vascular endothelial dysfunction and PA remodeling. SKL attenuates monocrotaline-induced PA remodeling and PA smooth muscle cell proliferation, likely by reducing inflammation and restoring SIRT1 levels and eNOS activity.
From the Department of Physiology, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City.
Rohan
R
Varshney
From the Department of Physiology, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City.
Quaisar
Q
Ali
From the Department of Physiology, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City.
Chengxiang
C
Wu
From the Department of Physiology, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City. Zhongjie-Sun@ouhsc.edu.
Zhongjie
Z
Sun
D000704:Analysis of Variance; D000818:Animals; D015153:Blotting, Western; D002478:Cells, Cultured; D004195:Disease Models, Animal; D015536:Down-Regulation; D005966:Glucuronidase / Q000235:genetics*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced / Q000235:genetics / Q000503:physiopathology*; D017380:Hypertrophy, Right Ventricular / Q000235:genetics* / Q000503:physiopathology; D000090265:Klotho Proteins; D008297:Male; D059630:Mesenchymal Stem Cells / Q000187:drug effects / Q000378:metabolism; D016686:Monocrotaline / Q000494:pharmacology; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism*; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D012680:Sensitivity and Specificity; D056564:Sirtuin 1 / Q000235:genetics; D014162:Transfection
D016686:Monocrotaline; D052250:Nitric Oxide Synthase Type III; D005966:Glucuronidase; D000090265:Klotho Proteins; C488368:Sirt1 protein, rat; D056564:Sirtuin 1
Klotho protein; SIRT1 protein, human; familial primary pulmonary hypertension; genetic therapy; mesenchymal stromal cells
J Huazhong Univ Sci Technolog Med Sci. 2012 Dec;32(6):810-7
23271278
Cell Stem Cell. 2012 Mar 2;10(3):244-58
22385653
Hum Gene Ther. 2012 Sep;23(9):1016-26
22888847
Diabetes. 2015 Dec;64(12 ):4298-311
26340932
Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10268-73
20479254
Basic Res Cardiol. 2010 May;105(3):409-17
19838762
J Gene Med. 2003 Dec;5(12):1028-38
14661178
Stem Cells. 2016 Jun;34(6):1615-25
26865060
Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1606-16
19783775
Stem Cells Dev. 2014 Feb 15;23(4):319-32
24171705
J Mol Cell Cardiol. 2008 Oct;45(4):514-22
18304573
Nature. 1997 Nov 6;390(6655):45-51
9363890
Stem Cells. 2013 Oct;31(10):2033-41
23766124
Hypertension. 2015 Nov;66(5):1006-13
26324504
Mol Med Rep. 2015 Aug;12(2):1983-90
25873020
Pulm Circ. 2011 Jul-Sep;1(3):430-1
22140634
Mol Med. 2014 Apr 22;20:191-201
24676136
Circulation. 2006 Jul 4;114(1 Suppl):I181-5
16820570
Hypertension. 2009 Oct;54(4):810-7
19635988
Can J Cardiol. 2014 Nov;30(11):1350-60
25442435
Hypertension. 2009 Sep;54(3):668-75
19597040
Hypertension. 2012 Sep;60(3):818-26
22777940
J Am Soc Nephrol. 2016 Jun;27(6):1765-76
26471128
Pharmacol Ther. 2014 Aug;143(2):181-96
24594234
Cell Cycle. 2011 Feb 15;10 (4):640-7
21293192
Aging Cell. 2016 Oct;15(5):853-60
27242197
Biochem Biophys Res Commun. 1998 Jul 20;248(2):324-9
9675134
Cell Transplant. 2012;21(7):1463-75
22525351
Biochem Biophys Res Commun. 2000 Sep 24;276(2):767-72
11027545
Hypertension. 2016 Mar;67(3):564-73
26781278
Endocr Rev. 2015 Apr;36(2):174-93
25695404
Clin Exp Pharmacol Physiol. 2010 Feb;37(2):150-5
19566840
J Surg Res. 2011 May 1;167(1):78-86
20869073
Vascul Pharmacol. 2012 Jan-Feb;56(1-2):64-73
22146233
Antioxid Redox Signal. 2011 Aug 15;15(4):967-80
20812875
Can J Cardiol. 2015 Apr;31(4):489-501
25840098
Exp Ther Med. 2012 Nov;4(5):839-843
23226736
Genes Dis. 2014 Sep 1;1(1):113-119
25642448
Endocrinology. 2013 Oct;154(10):3855-63
23928372
World J Stem Cells. 2014 Nov 26;6(5):526-39
25426250
Circulation. 2009 Apr 28;119(16):2250-94
19332472
Hypertension. 2014 Nov;64(5):1141-50
25185133
Am J Physiol Heart Circ Physiol. 2007 Feb;292(2):H1120-8
16980338
Diabetes. 2015 Apr;64(4):1444-58
25377875
Science. 2005 Sep 16;309(5742):1829-33
16123266
Cardiovasc Ther. 2010 Oct;28(5):e101-10
21050418
J Am Soc Nephrol. 2015 Jan;26(1):121-32
24904083
J Hypertens. 2010 Feb;28(2):201-12
20051913
J Hypertens. 2014 Aug;32(8):1629-36; discussion 1636
24979306
Aging Cell. 2012 Jun;11(3):410-7
22260450